At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 220 enrolled
Drug / intervention
metoclopramide +2 moredrug
Likely dose
metoclopramide 10mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Corticosteroids for Acute Migraine. An ED-based, Randomized, Comparative Effectiveness Trial
In Brief
A Phase 4 clinical trial evaluating metoclopramide, Dexamethasone, and 1 other intervention for Migraine. Completed, enrolled 220 participants across 2 sites.
Detailed Summary
This is an emergency department based randomized trial in which we compare two different treatment for migraine headache. The goal is to decrease the number of headache days during the week after ED discharge.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedJul 2016
Enrollment StartSep 2016
Primary CompletionSep 2017
Study CompletionSep 2017
TodayJul 2026
First PostedJul 28, 2016
Enrollment StartSep 1, 2016
Primary CompletionSep 21, 2017
Study CompletionSep 30, 2017
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.9 years ago
Interventions
metoclopramidedrug
metoclopramide 10mg intravenous infusion over 15 minutes
Dexamethasonedrug
dexamethasone 10mg intramuscular injection
methylprednisolone acetatedrug
methylprednislone acetate 160mg intramuscular injection